feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Lipum: Approval To Initiate Phase I Trial
Research Note
2022-09-27
16:55
Redeye leaves a short comment on Lipum’s announcement of a CTA approval for the phase I trial with SOL-116.
KS
Kevin Sule
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans